IRIS Accounts Production v24.1.4.33 12880144 director 1.10.22 30.9.23 30.9.23 false true false false true false Ordinary 1.00000 Ordinary A 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh128801442022-09-30128801442023-09-30128801442022-10-012023-09-30128801442021-09-30128801442021-10-012022-09-30128801442022-09-3012880144ns15:EnglandWales2022-10-012023-09-3012880144ns14:PoundSterling2022-10-012023-09-3012880144ns10:Director12022-10-012023-09-3012880144ns10:PrivateLimitedCompanyLtd2022-10-012023-09-3012880144ns10:SmallEntities2022-10-012023-09-3012880144ns10:AuditExempt-NoAccountantsReport2022-10-012023-09-3012880144ns10:SmallCompaniesRegimeForDirectorsReport2022-10-012023-09-3012880144ns10:SmallCompaniesRegimeForAccounts2022-10-012023-09-3012880144ns10:FullAccounts2022-10-012023-09-3012880144ns10:OrdinaryShareClass12022-10-012023-09-3012880144ns10:OrdinaryShareClass22022-10-012023-09-3012880144ns5:CurrentFinancialInstruments2023-09-3012880144ns5:CurrentFinancialInstruments2022-09-3012880144ns5:Non-currentFinancialInstruments2023-09-3012880144ns5:Non-currentFinancialInstruments2022-09-3012880144ns5:ShareCapital2023-09-3012880144ns5:ShareCapital2022-09-3012880144ns5:RetainedEarningsAccumulatedLosses2023-09-3012880144ns5:RetainedEarningsAccumulatedLosses2022-09-3012880144ns10:RegisteredOffice2022-10-012023-09-3012880144ns5:PlantMachinery2022-09-3012880144ns5:PlantMachinery2022-10-012023-09-3012880144ns5:PlantMachinery2023-09-3012880144ns5:PlantMachinery2022-09-3012880144ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-09-3012880144ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-09-3012880144ns10:OrdinaryShareClass12023-09-3012880144ns10:OrdinaryShareClass22023-09-30
REGISTERED NUMBER: 12880144 (England and Wales)















Unaudited Financial Statements for the Year Ended 30 September 2023

for

Dr Smile Limited

Dr Smile Limited (Registered number: 12880144)






Contents of the Financial Statements
for the Year Ended 30 September 2023




Page

Balance Sheet 1

Notes to the Financial Statements 3


Dr Smile Limited (Registered number: 12880144)

Balance Sheet
30 September 2023

30.9.23 30.9.22
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 33,880 38,332

CURRENT ASSETS
Debtors 5 - 4,390
Cash at bank 33,414 17,576
33,414 21,966
CREDITORS
Amounts falling due within one year 6 19,967 16,194
NET CURRENT ASSETS 13,447 5,772
TOTAL ASSETS LESS CURRENT
LIABILITIES

47,327

44,104

CREDITORS
Amounts falling due after more than one
year

7

16,172

24,129
NET ASSETS 31,155 19,975

CAPITAL AND RESERVES
Called up share capital 8 100 100
Retained earnings 31,055 19,875
SHAREHOLDERS' FUNDS 31,155 19,975

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Dr Smile Limited (Registered number: 12880144)

Balance Sheet - continued
30 September 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 24 June 2024 and were signed by:





Dr Z Rehman - Director


Dr Smile Limited (Registered number: 12880144)

Notes to the Financial Statements
for the Year Ended 30 September 2023

1. STATUTORY INFORMATION

Dr Smile Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 12880144

Registered office: 1st Floor
Spitalfields House
Stirling Way
Borehamwood
WD6 2FX

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Dr Smile Limited (Registered number: 12880144)

Notes to the Financial Statements - continued
for the Year Ended 30 September 2023

2. ACCOUNTING POLICIES - continued

Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Fixtures and fittings25% straight line basis
Motor vehicles33% straight line basis
IT equipments25% straight line basis

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Impairment of fixed assets
At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

Dr Smile Limited (Registered number: 12880144)

Notes to the Financial Statements - continued
for the Year Ended 30 September 2023

2. ACCOUNTING POLICIES - continued

Financial instruments
The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Equity instruments
Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


Dr Smile Limited (Registered number: 12880144)

Notes to the Financial Statements - continued
for the Year Ended 30 September 2023

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2022 - 2 ) .

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 October 2022 51,344
Additions 8,550
At 30 September 2023 59,894
DEPRECIATION
At 1 October 2022 13,012
Charge for year 13,002
At 30 September 2023 26,014
NET BOOK VALUE
At 30 September 2023 33,880
At 30 September 2022 38,332

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.23 30.9.22
£    £   
Other debtors - 4,390

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.23 30.9.22
£    £   
Hire purchase contracts 8,673 8,673
Taxation and social security 8,997 7,121
Other creditors 2,297 400
19,967 16,194

Dr Smile Limited (Registered number: 12880144)

Notes to the Financial Statements - continued
for the Year Ended 30 September 2023

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
30.9.23 30.9.22
£    £   
Hire purchase contracts 16,172 24,129

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 30.9.23 30.9.22
value: £    £   
95 Ordinary 1 95 95
5 Ordinary A 1 5 5
100 100

Ordinary shares have full rights in the company with respect to voting, dividends and distribution.

Ordinary A shares have full rights in the company with respect to dividends only.

9. ULTIMATE CONTROLLING PARTY

The company is controlled by the director.